Viewing Study NCT01719250


Ignite Creation Date: 2025-12-24 @ 5:14 PM
Ignite Modification Date: 2025-12-28 @ 10:48 AM
Study NCT ID: NCT01719250
Status: COMPLETED
Last Update Posted: 2018-10-09
First Post: 2012-10-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Sponsor: Mayo Clinic
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module